St. Louis Intellectual Property Attorney David VanVliet Published in Bloomberg BNA

Bloomberg BNA
March 10, 2016 Publications

Associate David VanVliet recently wrote an article regarding Pharmaceutical Polymorphs and Patentability, which was published by Bloomberg BNA. 

In the article, VanVliet explains polymorphs, why they matter, whether they are anticipated or obvious, and how to overcome potential rejection. 

To read the full article, click here.